Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-24

Clinical Trial Update: Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of 0.12% chlorhexidine gluconate for peri-implant mucositis and peri-implant gingivitis has completed the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine gluconate 0.12% oral rinse (chlorhexidine gluconate)

Snippet

Sponsor: Universidade Federal do Rio Grande do Norte | Conditions: Mucositis, Gingivitis | Phase 2 | Status: COMPLETED